Beruflich Dokumente
Kultur Dokumente
Symptoms of the swine flu are very similar to those of seasonal influenza and include fever, cough, sore throat, body aches, headache, chills and fatigue. Some people have reported diarrhea and vomiting associated with swine flu. In the past, severe illness (pneumonia and respiratory failure) and deaths have been reported with swine flu infection in people. Like seasonal flu, swine flu may cause a worsening of underlying chronic medical conditions.
The US CDC recommends the use of oseltamivir (Tamiflu) or zanamivir (Relenza) for the treatment and/or prevention of infection with these swine influenza viruses.
OSELTAMIVIR (TAMIFLU)
TAMIFLU (oseltamivir phosphate) is available as capsules containing 30 mg, 45 mg, or 75 mg oseltamivir for oral use, in the form of oseltamivir phosphate, and as a powder for oral suspension
Dissociation Constants: pKa = 7.7 at 25 deg C (primary amine) Solubility: In water, 1.6X10^3 mg/L at 25 deg C (est) Vapor Pressure: 1.3X10^8 mm Hg at 25 deg C (est) Molecular weight: 410.40. White crystalline solid H-Bond Donor: 2 H Bond Acceptor: 5 Exact Mass: 312.204907 g/mol
Working of Tamiflu
Neuraminidases, also called sialidases, catalyze the breakage of the pathogen from the newly formed virions and from the host cell receptors Neuraminidase inhibitors are a class of antiviral drugs targeted at the influenza virus, which work by blocking the function of the viral neuraminidase protein, thus preventing the virus from reproducing by budding from the host cell.
Viral neuraminidase is a type of neuraminidase found on the surface of influenza viruses that enables the virus to be released from the host cell. http://www.pharmasquare.org/flash/Tamiflu.html
The dose for a child 30-75 mg per day. Depending the weight of the child.
ZANAMIVIR (RELENZA)
BASIC PROPERTIES
IUPAC Name: (2R,3R,4S)-3-acetamido-4(diaminomethylideneamino)-2-[(1R,2R)-1,2,3trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid
OSELTAMIVIR VS ZANAMIVR
Influenza virus is a constantly mutating virus. Because of its high frequency of mutations, leading to change of its structure, it escapes immunity that humans develop against the virus. Recently, it has also been reported to have developed resistance to anti-viral drugs. So far, cases of viral resistance have been reported only against Tamiflu, whereas no viral resistance has been observed against Relenza, a finding that can have very significant implications in favor of Relenza in the long run. Recently, both the Center for Disease Control and Prevention (CDC) and the World Health Organization (WHO) have acknowledged in their reports that there is widespread resistance to Tamiflu in treating the H1N1 virus, the strain that caused the 2009 flu pandemic, with almost 99.6 % samples being resistant, against only 12% resistance an year earlier. The high incidence of viral resistance in the case of Tamiflu will make it less useful for treating influenza, a fact that can tilt the priorities in favor of Relenza, which has so far been free of the viral resistance problem.
Drug Resistance
THANK YOU